| |
 |
|
Home > In Vitro Diagnostics > Top 10 Companies > Leading Diagnostics Companies R&D Expenditures and Major Programs
|
Leading Diagnostics Companies R&D Expenditures and Major Programs
|
|
 |
 |
For each company, the report provides:- R&D budget, research facilities, and staff.
- New technologies, systems, and applications in development, including their specifications and anticipated introduction dates.
The companies analyzed in the report: Abbott, Bayer Diabetes, Beckman Coulter, Becton Dickinson, bioMerieux, Bio-Rad, J&J, Roche, Siemens, and Sysmex.Contains 57 pages
|
|
 |
| |
|
|
| |
|
|
|
Local PDF: $2450.00
Other Formats: Global PDF, Print
|
 |
| |
|
 |
| |
|
|
|